December 11, 2018

We are honored to continue working with our partners around the world. Webinar on Building Capacity in Physical Therapy, took place December 6, 2018. Webinar BEYOND OUR BORDERS: BUILDING PHYSICAL THERAPY CAPACITY was co-presented by Kathy Clark (PT, MS, DPT) from Boston Biopharma CSR team and April Pinner (MSPH, RD) from Health Volunteers Overseas (HVO) moderated by April Gamble (PT, DPT).


The event is sponsored by the Global Health Special Interest Group (GHSIG) and the American Physical Therapy Association (APTA). 

Introducing Leugon (Leuprorelin)

October 08, 2018

Implant in a prefilled syringe


  • Leugon is an implant in prefilled syringe that contains Leuprorelin acetate.

  • Leuprorelin acetate is a synthetic nonapeptide analog of naturally occurring gonadotropin releasing hormone (GnRH or LHRH).

  • Leugon is a long-acting formulation. Leugon 11.25 mg corresponds to 10.72 mg Leuprorelin.

Introducing Golexin (Goserelin)

October 08, 2018

Implant in a prefilled syringe


  • Golexin is an implant in prefilled syringe that contains goserelin acetate.

  • Golexin is hormone therapy, classified as "LHRH agonist."

  • Golexin is a long-acting formulation: 3.6 mg (one month).

April 16, 2018

April 17, 2018 marks the 28th World Hemophilia Day! Boston Biopharma is committed to share knowledge and increase awareness about hemophilia, our goal is to improve access to care and treatment. Boston Biopharma CSR team is working toward bringing awareness to the medical community and families during World Hemophilia Day 2018.


2018 Microsoft Health Innovation Awards

March 07, 2018

Congratulations to all the Winners of the 2018 Microsoft Health Innovation Awards! BB team is honored that Dr. Ahmad Hashem the CEO of Boston Biopharma is a distinguished judge who reviewed this year’s innovative solutions award. Discover how they're advancing digital transformation in health.

Clinical Skills Training

March 06, 2018

In the first phase of a capacity building project to improve the clinical skills of Kurdish health care providers who work with children who have hemophilia, Dr. April Gamble, a doctor of physical therapy, spent two months training the nurses at Nanakali Hospital how to work with this population. The training includes how to address acute bleeds and guidelines for returning to activity, including exercise prescription. 

During the next phase, these nurse trainers will use their new found skills to educate and empower children with hemophilia and their families."

Please reload